Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00659490 · ClinicalTrials.gov registry record · Phase 2
Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1940
A Phase 2 study, sponsored by AstraZeneca.
- Completed
- Registry status
- Phase 2
- Development phase
- 151
- Enrollment target
NCT00659490 is a Phase 2 study that has completed, run by AstraZeneca. The registered enrollment target is 151 participants.
The verdict
NCT00659490, a Phase 2 study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 151 participants
- Enrollment target
Study Summary
The primary aim of this study is to investigate if AZD1940 can relieve the pain induced by the surgical removal of one lower wisdom-tooth. This will be done by comparing the effect of AZD1940 to placebo ("inactive substance") on pain. A number of patients will instead receive the common painkiller naproxen for comparison purposes. Rescue medication, acetaminophen, will be allowed if a need for additional painkillers would arise. A number of patients will receive Naproxen as control.
Interventions
- DRUG Placebo
- DRUG Naproxen
- DRUG AZD1940
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 151 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00659490
The ClinicalTrials.gov registry entry for NCT00659490 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 151 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AstraZeneca, which has 1,285 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT00659490 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00659490 about?
NCT00659490 is a clinical study titled "Study to Investigate the Analgesic Efficacy of a Single Dose of AZD1940". The primary aim of this study is to investigate if AZD1940 can relieve the pain induced by the surgical removal of one lower wisdom-tooth. This will be done by comparing the effect of AZD1940 to placebo ("inactive substance") on pain. A number of patients will instead receive the common painkiller n...
What is the current status of trial NCT00659490?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 151 participants. The study started on 2008-02. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00659490?
The interventions under investigation include: Placebo (DRUG), Naproxen (DRUG), AZD1940 (DRUG).
Who is sponsoring clinical trial NCT00659490?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.